Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex


Presynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference was detected in SV2A protein levels in levetiracetam… (More)
DOI: 10.3389/fncel.2017.00389


8 Figures and Tables

Slides referencing similar topics